Lincoln Pharmaceuticals Ltd vs Zota Health Care Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Lincoln Pharmaceuticals Ltd is ₹ 681.05 as of 18 May 15:30 . The P/E Ratio of Lincoln Pharmaceuticals Ltd changed from 7.2 on March 2021 to 13.4 on March 2025 . This represents a CAGR of 13.23% over 5 yearsThe P/E Ratio of Zota Health Care Ltd changed from 84.1 on March 2022 to 0 on March 2025 . This represents a CAGR of -100.00% over 4 years The Market Cap of Lincoln Pharmaceuticals Ltd changed from ₹ 449.4 crore on March 2021 to ₹ 1104 crore on March 2025 . This represents a CAGR of 19.71% over 5 yearsThe Market Cap of Zota Health Care Ltd changed from ₹ 340.16 crore on March 2021 to ₹ 2306 crore on March 2025 . This represents a CAGR of 46.64% over 5 years The revenue of Lincoln Pharmaceuticals Ltd for the Dec '25 is ₹ 181.47 crore as compare to the Sep '25 revenue of ₹ 170.6 crore. This represent the growth of 6.37% The revenue of Zota Health Care Ltd for the Dec '25 is ₹ 144.67 crore as compare to the Sep '25 revenue of ₹ 130.58 crore. This represent the growth of 10.79% The ebitda of Lincoln Pharmaceuticals Ltd for the Dec '25 is ₹ 38.74 crore as compare to the Sep '25 ebitda of ₹ 32.66 crore. This represent the growth of 18.62% The ebitda of Zota Health Care Ltd for the Dec '25 is ₹ 1.28 crore as compare to the Sep '25 ebitda of ₹ 7.96 crore. This represent the decline of -83.92% The net profit of Lincoln Pharmaceuticals Ltd changed from ₹ 23.67 crore to ₹ 28.6 crore over 7 quarters. This represents a CAGR of 11.42% The net profit of Zota Health Care Ltd changed from ₹ -12.72 crore to ₹ -29.64 crore over 7 quarters. This represents a CAGR of 62.16% The Dividend Payout of Lincoln Pharmaceuticals Ltd changed from 4.83 % on March 2021 to 4.38 % on March 2025 . This represents a CAGR of -1.94% over 5 yearsThe Dividend Payout of Zota Health Care Ltd changed from -1535 % on March 2021 to 33.23 % on March 2025 . This represents a CAGR of NaN% over 5 years .

About Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in January, 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. '95.
All the assets and business of the erstwhile partnership were transferred to the Company.
The Company is engaged in the business of manufacturing and trading of pharmaceutical products.
The focused area includes anti-infective, respiratory system, gynecology, cardio & CNS, anti-diabetic, anti malaria, among others. The Company, incorporated in January, 1995, was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982.
It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments.

About Zota Health Care Ltd

Zota Health Care Limited is a renowned pharmaceutical company that manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over-the-counter (OTC) products.
The Company was incorporated in July 12, 2000 and is based out of Surat, Gujarat.
The Company meets the requirements of millions of people by increasing access to high-quality, affordable medicines for chronic illnesses including heart disease, diabetes, thyroid disease, and others, giving India's pharmaceutical industry a boost. The Company has three business verticals: Marketing-a traditional business vertical, and driving business verticals - Exports and Retail harmacy Chain.
Through its chain, Davaindia, the largest private-sector generic pharmacy chain, the Company is making strong inroads into the generic retail pharmacy business.

FAQs for the comparison of Lincoln Pharmaceuticals Ltd and Zota Health Care Ltd

Which company has a larger market capitalization, Lincoln Pharmaceuticals Ltd or Zota Health Care Ltd?

Market cap of Lincoln Pharmaceuticals Ltd is 1,364 Cr while Market cap of Zota Health Care Ltd is 4,155 Cr

What are the key factors driving the stock performance of Lincoln Pharmaceuticals Ltd and Zota Health Care Ltd?

The stock performance of Lincoln Pharmaceuticals Ltd and Zota Health Care Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Lincoln Pharmaceuticals Ltd and Zota Health Care Ltd?

As of May 18, 2026, the Lincoln Pharmaceuticals Ltd stock price is INR ₹681.05. On the other hand, Zota Health Care Ltd stock price is INR ₹1199.9.

How do dividend payouts of Lincoln Pharmaceuticals Ltd and Zota Health Care Ltd compare?

To compare the dividend payouts of Lincoln Pharmaceuticals Ltd and Zota Health Care Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.